Clinical Trial Update: Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on continuous amnioinfusion for treatment of classic mid-trimester preterm premature rupture of membranes (PPROM).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Intracranial Hemorrhages
• Necrotizing Enterocolitis

Snippet

Sponsor: Martin-Luther-Universität Halle-Wittenberg | Conditions: Bronchopulmonary Dysplasia, Necrotizing Enterocolitis | Phase 3 | Status: UNKNOWN